Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to learn if the study drug RAD001 can shrink or slow
the growth of low-grade gliomas. Additionally, the safety of RAD001 will be studied. RAD001
is a drug that may act directly on tumor cells by inhibiting tumor cell growth and
proliferation.